High-Level Overview
Custom Biogenic Systems (CBS) is a Michigan-based manufacturer of cryogenic storage solutions for laboratories, specializing in advanced equipment like isothermal freezers using dry liquid nitrogen technology, cryogenic freezers, controlled rate freezers, racks, canisters, and monitoring accessories.[1][2][3] It serves pharmaceutical, biobank, medical, research, and industrial sectors in life sciences by enabling safe, efficient preservation of biological samples.[1][2][3] Founded in 1987, CBS generated an estimated $15 million in revenue in 2024 before its acquisition by Standex International in November 2024 for $6.2 million, marking a pivotal growth milestone as it integrates into a larger scientific products portfolio.[1][2]
Origin Story
CBS was founded in 1987 in Bruce Township (Macomb), Michigan, to meet the demand for reliable cryogenic storage in life sciences, with John Brothers listed as owner.[1][3][4] From its early years, the company emphasized innovation in cryopreservation, developing products like upright and chest freezer racks, liquid nitrogen systems, and inventory tools.[3] Key evolution included breakthroughs in isothermal freezers with dry liquid nitrogen jackets for safer storage, alongside market expansion domestically and internationally over 30+ years, building a reputation for quality and customer service.[3] A defining moment came in November 2024 when Standex acquired CBS, accretive to earnings and expanding its scientific segment.[2]
Core Differentiators
- Innovative Technology: Pioneered isothermal freezers with dry liquid nitrogen jackets, minimizing risks like liquid nitrogen exposure while ensuring uniform, efficient cryogenic storage.[1][2][3]
- Comprehensive Product Range: Offers cryogenic freezers, controlled rate freezers, racks (upright, chest, LN2), canisters, frames, laboratory boxes, dividers, and monitoring systems for organized sample management.[1][3][4]
- Proven Expertise and Reliability: Over 37 years of leadership in life sciences, with high-quality manufacturing tailored to pharmaceutical and biobank needs, supported by exceptional customer service.[1][2][3]
- Engineering and Customization: Strong R&D focus enables custom cryogenic solutions, inventory systems, and accessories, positioning it as a one-stop provider for lab cryopreservation.[3][4]
Role in the Broader Tech Landscape
CBS rides the wave of expanding biobanking, personalized medicine, and biotech R&D, where secure cryogenic storage is critical for preserving cells, tissues, and vaccines amid rising demand for long-term sample integrity.[1][2][3] Timing aligns with post-pandemic growth in life sciences infrastructure, as labs scale for gene therapies and regenerative medicine, favoring reliable, innovative equipment over traditional methods.[3] Market forces like regulatory demands for sample safety and efficiency boost CBS's dry nitrogen tech, which reduces contamination risks.[1][2] Its acquisition by Standex amplifies influence, integrating CBS into a global multi-industry manufacturer to enhance scientific offerings and accelerate adoption in research ecosystems.[2]
Quick Take & Future Outlook
Post-acquisition, CBS will leverage Standex's resources for R&D expansion, global distribution, and product integration, potentially driving revenue beyond $15 million through cross-selling in electronics and engineering segments.[2] Trends like AI-driven biobanking, cryo-preservation for organoids, and sustainable cooling will shape its path, with dry nitrogen tech gaining traction for safer, greener labs.[1][3] Expect evolved influence as a Standex pillar, influencing standards in cryogenic innovation and solidifying its legacy from niche leader to scaled life sciences enabler—echoing its founding mission of reliable preservation at the forefront of biotech progress.[2][3]